These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 24594481)

  • 1. Role of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH).
    Jha P; Knopf A; Koefeler H; Mueller M; Lackner C; Hoefler G; Claudel T; Trauner M
    Biochim Biophys Acta; 2014 Jul; 1842(7):959-70. PubMed ID: 24594481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia.
    Jha P; Claudel T; Baghdasaryan A; Mueller M; Halilbasic E; Das SK; Lass A; Zimmermann R; Zechner R; Hoefler G; Trauner M
    Hepatology; 2014 Mar; 59(3):858-69. PubMed ID: 24002947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet.
    Tanaka N; Takahashi S; Zhang Y; Krausz KW; Smith PB; Patterson AD; Gonzalez FJ
    Biochim Biophys Acta; 2015 Jul; 1852(7):1242-52. PubMed ID: 25736301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice.
    Fuchs CD; Radun R; Dixon ED; Mlitz V; Timelthaler G; Halilbasic E; Herac M; Jonker JW; Ronda OAHO; Tardelli M; Haemmerle G; Zimmermann R; Scharnagl H; Stojakovic T; Verkade HJ; Trauner M
    Hepatology; 2022 Jan; 75(1):125-139. PubMed ID: 34387896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transition from fatty liver to NASH associates with SAMe depletion in db/db mice fed a methionine choline-deficient diet.
    Wortham M; He L; Gyamfi M; Copple BL; Wan YJ
    Dig Dis Sci; 2008 Oct; 53(10):2761-74. PubMed ID: 18299981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A methionine-choline-deficient diet induces nonalcoholic steatohepatitis and alters the lipidome, metabolome, and gut microbiome profile in the C57BL/6J mouse.
    Gautam J; Aggarwal H; Kumari D; Gupta SK; Kumar Y; Dikshit M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2024 Dec; 1869(8):159545. PubMed ID: 39089643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.
    Fisher FM; Chui PC; Nasser IA; Popov Y; Cunniff JC; Lundasen T; Kharitonenkov A; Schuppan D; Flier JS; Maratos-Flier E
    Gastroenterology; 2014 Nov; 147(5):1073-83.e6. PubMed ID: 25083607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet.
    Tanaka N; Takahashi S; Fang ZZ; Matsubara T; Krausz KW; Qu A; Gonzalez FJ
    Biochim Biophys Acta; 2014 Nov; 1841(11):1596-607. PubMed ID: 25178843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model.
    Rein-Fischboeck L; Haberl EM; Pohl R; Schmid V; Feder S; Krautbauer S; Liebisch G; Buechler C
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):526-537. PubMed ID: 29474931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice.
    Haque JA; McMahan RS; Campbell JS; Shimizu-Albergine M; Wilson AM; Botta D; Bammler TK; Beyer RP; Montine TJ; Yeh MM; Kavanagh TJ; Fausto N
    Lab Invest; 2010 Dec; 90(12):1704-17. PubMed ID: 20548286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent changes and association between liver free fatty acids, serum lipid profile and histological features in mice model of nonalcoholic fatty liver disease.
    Stanković MN; Mladenović DR; Duričić I; Šobajić SS; Timić J; Jorgačević B; Aleksić V; Vučević DB; Ješić-Vukićević R; Radosavljević TS
    Arch Med Res; 2014 Feb; 45(2):116-24. PubMed ID: 24480733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
    Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis.
    Reid BN; Ables GP; Otlivanchik OA; Schoiswohl G; Zechner R; Blaner WS; Goldberg IJ; Schwabe RF; Chua SC; Huang LS
    J Biol Chem; 2008 May; 283(19):13087-99. PubMed ID: 18337240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4,4-Diallyl curcumin bis(2,2-hydroxymethyl)propanoate ameliorates nonalcoholic steatohepatitis in methionine-choline-deficient diet and Western diet mouse models.
    Yang LC; Wang CC; Lee DY; Lin WC; Kuo SC; Juang SH; Hsieh MT
    Chem Biol Drug Des; 2024 May; 103(5):e14532. PubMed ID: 38725089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methionine- and Choline-Deficient Diet Enhances Adipose Lipolysis and Leptin Release in aP2-Cre Fatp4-Knockout Mice.
    Cheng Y; Gan-Schreier H; Seeßle J; Staffer S; Tuma-Kellner S; Khnykin D; Stremmel W; Merle U; Herrmann T; Chamulitrat W
    Mol Nutr Food Res; 2020 Nov; 64(22):e2000361. PubMed ID: 32991778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid.
    Yoo W; Gjuka D; Stevenson HL; Song X; Shen H; Yoo SY; Wang J; Fallon M; Ioannou GN; Harrison SA; Beretta L
    PLoS One; 2017; 12(12):e0189965. PubMed ID: 29244873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis.
    Jung YA; Choi YK; Jung GS; Seo HY; Kim HS; Jang BK; Kim JG; Lee IK; Kim MK; Park KG
    Diabetes Res Clin Pract; 2014 Jul; 105(1):47-57. PubMed ID: 24842243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient diet.
    Carril E; Valdecantos MP; Lanzón B; Angulo S; Valverde ÁM; Godzien J; Rupérez FJ
    J Pharm Biomed Anal; 2020 Jan; 178():112958. PubMed ID: 31718984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice.
    Itagaki H; Shimizu K; Morikawa S; Ogawa K; Ezaki T
    Int J Clin Exp Pathol; 2013; 6(12):2683-96. PubMed ID: 24294355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.